KR20210143254A - 마취 조성물 및 안구의 마취 방법 - Google Patents
마취 조성물 및 안구의 마취 방법 Download PDFInfo
- Publication number
- KR20210143254A KR20210143254A KR1020217034148A KR20217034148A KR20210143254A KR 20210143254 A KR20210143254 A KR 20210143254A KR 1020217034148 A KR1020217034148 A KR 1020217034148A KR 20217034148 A KR20217034148 A KR 20217034148A KR 20210143254 A KR20210143254 A KR 20210143254A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- articaine
- mannitol
- borate
- complex
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962824207P | 2019-03-26 | 2019-03-26 | |
US62/824,207 | 2019-03-26 | ||
USPCT/US2019/024239 | 2019-03-27 | ||
PCT/US2019/024239 WO2019191200A1 (en) | 2018-03-27 | 2019-03-27 | Method and formulation for producing anesthesia of internal aspect of eye wall by topical application |
US16/811,798 US11096922B2 (en) | 2018-03-27 | 2020-03-06 | Anesthetic composition and method of anesthetizing the eye |
US16/811,798 | 2020-03-06 | ||
PCT/US2020/022915 WO2020197816A1 (en) | 2019-03-26 | 2020-03-16 | Anesthetic composition and method of anesthetizing the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210143254A true KR20210143254A (ko) | 2021-11-26 |
Family
ID=72609654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217034148A KR20210143254A (ko) | 2019-03-26 | 2020-03-16 | 마취 조성물 및 안구의 마취 방법 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3946311A4 (zh) |
JP (1) | JP2022527621A (zh) |
KR (1) | KR20210143254A (zh) |
CN (1) | CN114072139A (zh) |
AU (1) | AU2020245203A1 (zh) |
BR (1) | BR112021019039A2 (zh) |
CA (1) | CA3134531A1 (zh) |
IL (1) | IL286624A (zh) |
MX (1) | MX2021011589A (zh) |
SG (1) | SG11202110423UA (zh) |
WO (1) | WO2020197816A1 (zh) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69333850T3 (de) * | 1992-05-06 | 2011-03-17 | Alcon Laboratories, Inc., Fort Worth | Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen |
ES2383003T3 (es) * | 2001-11-21 | 2012-06-15 | Carl Zeiss Meditec Sas | Composición para estabilizar ácido hialurónico |
CN101695488B (zh) * | 2009-11-05 | 2012-05-02 | 蚌埠丰原涂山制药有限公司 | 复方阿替卡因注射用冻干制剂及其制备方法 |
CN101721407B (zh) * | 2009-11-23 | 2013-04-10 | 蚌埠丰原涂山制药有限公司 | 复方盐酸阿替卡因注射液及其制备方法 |
FR2968996B1 (fr) * | 2010-12-17 | 2013-04-12 | Anteis Sa | Formulation aqueuse injectable sterile utilisee en ophtalmologie |
FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
JP2018526423A (ja) * | 2015-09-08 | 2018-09-13 | ビューポイント セラピューティクス, インコーポレイテッド | 眼科疾患を処置するための化合物および製剤 |
WO2018220283A1 (fr) * | 2017-05-29 | 2018-12-06 | Kh Medtech Sarl | Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine |
-
2020
- 2020-03-16 SG SG11202110423UA patent/SG11202110423UA/en unknown
- 2020-03-16 MX MX2021011589A patent/MX2021011589A/es unknown
- 2020-03-16 AU AU2020245203A patent/AU2020245203A1/en active Pending
- 2020-03-16 KR KR1020217034148A patent/KR20210143254A/ko unknown
- 2020-03-16 CA CA3134531A patent/CA3134531A1/en active Pending
- 2020-03-16 EP EP20776365.7A patent/EP3946311A4/en active Pending
- 2020-03-16 JP JP2021560140A patent/JP2022527621A/ja active Pending
- 2020-03-16 CN CN202080033483.9A patent/CN114072139A/zh active Pending
- 2020-03-16 BR BR112021019039A patent/BR112021019039A2/pt unknown
- 2020-03-16 WO PCT/US2020/022915 patent/WO2020197816A1/en active Application Filing
-
2021
- 2021-09-23 IL IL286624A patent/IL286624A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3134531A1 (en) | 2020-10-01 |
IL286624A (en) | 2021-10-31 |
WO2020197816A1 (en) | 2020-10-01 |
MX2021011589A (es) | 2021-12-15 |
EP3946311A4 (en) | 2022-12-28 |
SG11202110423UA (en) | 2021-10-28 |
AU2020245203A1 (en) | 2021-11-11 |
BR112021019039A2 (pt) | 2021-11-30 |
JP2022527621A (ja) | 2022-06-02 |
EP3946311A1 (en) | 2022-02-09 |
CN114072139A (zh) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230181497A1 (en) | Ketorolac tromethamine compositions for treating or preventing ocular pain | |
KR101809713B1 (ko) | 방부제 없는 프로스타글란딘계 비점성 용액의 고분자 전달 시스템 | |
KR20120112537A (ko) | 무자극성 안과용 포비돈-요오드 조성물 | |
CN103747786A (zh) | 比马前列素和溴莫尼定的固定剂量组合 | |
AU2021221401B2 (en) | Stable peptide compositions | |
US20240041824A1 (en) | Anesthetic composition and method of anesthetizing the eye | |
JP6934581B2 (ja) | エピナスチン又はその塩を含有する水性医薬組成物 | |
EP4029493A1 (en) | Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof | |
JP2017525758A (ja) | リファマイシンの眼科用組成物およびその使用 | |
JP3502574B2 (ja) | 眼感染症治療用眼軟膏剤 | |
KR20210143254A (ko) | 마취 조성물 및 안구의 마취 방법 | |
RU2812900C2 (ru) | Анестезирующая композиция и способ анестезирования глаза | |
JP6963651B2 (ja) | エピナスチン又はその塩を含有する水性組成物 | |
CA3088185C (en) | Suspension compositions of multi-target inhibitors | |
WO2018123945A1 (ja) | タフルプロストとクエン酸エステルとを含有するデポ剤 | |
US20050130951A1 (en) | Superoxide dismutase mimics for the treatment of optic nerve and retinal damage | |
AU2017235979A1 (en) | Non-irritating ophthalmic povidone-iodine compositions | |
JP5299449B2 (ja) | 外用剤組成物 | |
WO2024135837A1 (ja) | 組織移行性及び防腐効力を向上させるエピナスチン含有水性組成物 | |
EA004050B1 (ru) | Способ изготовления состава местных бета-блокаторов улучшенного действия | |
JP2005187354A (ja) | 水性外用剤組成物 |